Blood marker may flag dangerous preeclampsia

NCT ID NCT06413576

Completed Diagnosis Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether measuring homocysteine levels in the blood can help predict how severe preeclampsia will become in pregnant women. Researchers measured homocysteine in 70 critically ill preeclampsia patients and analyzed its link to complications. The goal is to see if this simple test could help doctors identify high-risk patients earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood test to help doctors identify which preeclampsia patients are at highest risk of complications.
What could go wrong: This is a small, completed observational study, not a treatment trial. The findings need to be confirmed in larger, more diverse groups before any test could be widely used.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICAL ILLNESS PRE-ECLAMPSIA

Contacts and locations

Locations

Ain shams University

Cairo, Cairo Governorate, 11591, Egypt
Ain shams university

Cairo, Cairo Governorate, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.